Regeneron Pharmaceuticals REGN Otarmeni Gene Therapy Launch Shifts LongTerm Narrative Amid Pipeline Execution Focus TWO Two posts sharp 30 percent Q4 2025 EPS miss shares remain flat after earnings release MEGL Magic prioritizes global crossborder payment service expansion to drive longterm growth in its latest quarterly earnings release